company background image
FSNU.Y logo

Fresenius SE KGaA OTCPK:FSNU.Y Stock Report

Last Price

US$12.10

Market Cap

US$27.1b

7D

3.9%

1Y

59.4%

Updated

05 May, 2025

Data

Company Financials +

Fresenius SE & Co. KGaA

OTCPK:FSNU.Y Stock Report

Market Cap: US$27.1b

FSNU.Y Stock Overview

A health care company, provides products and services for chronically ill patients. More details

FSNU.Y fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance1/6
Financial Health4/6
Dividends4/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Fresenius SE & Co. KGaA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Fresenius SE KGaA
Historical stock prices
Current Share Price€12.10
52 Week High€12.13
52 Week Low€7.43
Beta0.96
1 Month Change16.79%
3 Month Change25.91%
1 Year Change59.41%
3 Year Change33.99%
5 Year Change9.70%
Change since IPO60.76%

Recent News & Updates

Recent updates

Shareholder Returns

FSNU.YUS HealthcareUS Market
7D3.9%-0.4%2.2%
1Y59.4%-9.6%8.2%

Return vs Industry: FSNU.Y exceeded the US Healthcare industry which returned -10% over the past year.

Return vs Market: FSNU.Y exceeded the US Market which returned 9.3% over the past year.

Price Volatility

Is FSNU.Y's price volatile compared to industry and market?
FSNU.Y volatility
FSNU.Y Average Weekly Movement4.3%
Healthcare Industry Average Movement7.7%
Market Average Movement7.8%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market4.1%

Stable Share Price: FSNU.Y has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: FSNU.Y's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1912176,486Michael Senwww.fresenius.com

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Fresenius SE & Co. KGaA Fundamentals Summary

How do Fresenius SE KGaA's earnings and revenue compare to its market cap?
FSNU.Y fundamental statistics
Market capUS$27.15b
Earnings (TTM)US$1.18b
Revenue (TTM)US$24.71b

23.0x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FSNU.Y income statement (TTM)
Revenue€21.83b
Cost of Revenue€16.46b
Gross Profit€5.38b
Other Expenses€4.34b
Earnings€1.04b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

May 07, 2025

Earnings per share (EPS)1.85
Gross Margin24.63%
Net Profit Margin4.77%
Debt/Equity Ratio59.5%

How did FSNU.Y perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

54%

Payout Ratio

Does FSNU.Y pay a reliable dividends?

See FSNU.Y dividend history and benchmarks
When do you need to buy FSNU.Y by to receive an upcoming dividend?
Fresenius SE KGaA dividend dates
Ex Dividend DateMay 27 2025
Dividend Pay DateJun 04 2025
Days until Ex dividend21 days
Days until Dividend pay date29 days

Does FSNU.Y pay a reliable dividends?

See FSNU.Y dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 05:30
End of Day Share Price 2025/05/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fresenius SE & Co. KGaA is covered by 47 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Hassan Al-WakeelBarclays
Robert BateBarclays